Significance of regenerating islet-derived type IV gene expression in gastroenterological cancers

doi:10.3748/wjg.v18.i27.3502

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 27

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3987)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

416

HTML

3201

Figures (1-1)

194

Tables (1-4)

176

Sum=3987

Jul 21, 2012 (publication date) through Jul 23, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jul 21, 2012; 18(27): 3502-3510
Published online Jul 21, 2012. doi: 10.3748/wjg.v18.i27.3502

Table 2 Articles reporting regenerating islet-derived type IV as anti-apoptic factor

Author	Year	Type of cancer	Result
Bishnupuri et al[46]	2006	Colorectal	RegIV induces cell survival against radiation, and regulates Bcl-2 and Bcl-xL
Mitani et al[19]	2007	Gastric	RegIV inhibited 5-fluorouracil-induced apoptosis, and induced DPD expression
Eguchi et al[44]	2009	Pancreatic	RegIV decreased the sensitivity to radiation and gemcitabine

RegIV: Reporting regenerating islet-derived type IV; Bcl-2: B-cell lymphoma 2; Bcl-xL: B-cell lymphoma-extra large; DPD: Dihydropyrimidine dehydrogenase.

Citation: Numata M, Oshima T. Significance of regenerating islet-derived type IV gene expression in gastroenterological cancers. World J Gastroenterol 2012; 18(27): 3502-3510
URL: https://www.wjgnet.com/1007-9327/full/v18/i27/3502.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i27.3502